LCM
ANGO icon

Legato Capital Management’s AngioDynamics ANGO Stock Holding History

Legato Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-116,567
Closed -$1.5M – 737
2025
Q4 		$1.5M Buy
116,567
+22,189
+24% +$274K 0.13% 246
2025
Q3 		$1.05M Buy
94,378
+25,619
+37% +$247K 0.11% 277
2025
Q2 		$682K Buy
68,759
+15,632
+29% +$153K 0.08% 375
2025
Q1 		$499K Buy
+53,127
New +$558K 0.07% 425

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Legato Capital Management's ANGO Position: Q1 2026 in Review

Legato Capital Management sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 116,567 shares — an estimated $1.5M sold.

Legato Capital Management first reported a position in ANGO in Q1 2025 and held it in 4 quarters. The position peaked at $1.5M in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Legato Capital Management reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • Legato Capital Management sold 116,567 AngioDynamics shares in Q1 2026, an estimated $1.5M.
  • Legato Capital Management first reported a position in AngioDynamics in Q1 2025 and held it in 4 quarters.
  • Legato Capital Management's AngioDynamics position peaked at $1.5M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.